Session 2 Drugs Crossword

Warning: Children with CYP2D6 ultra-fast metabolizer
Dosage forms: Cap (200mg), Suspension (200mg/5ml), Tab (400mg, 800mg)
Adverse side effect: malaise
Adverse side effect: Nausea, Pharyngitis, Rhinitis, Throat Irritation, Upper Respiratory Tract Infection
Pearl: not for chronic use without anti-inflammatory agent
Dosage Forms: Tab (5mg, 10mg, 35mg, 40mg, 70mg), Solution (70mg/75ml), Effervescent Tab (70mg)
Contraindicated in patients with esophageal abnormalities
Key counseling: adequate hydration to prevent kidney stones and avoid caffeine and alcohol
Pearl: adherence critical- full effect may take 2-6 weeks
Contraindicated in patients with narrow-angle glaucoma as well as concurrent use with ketoconazole or itraconazole
Key counseling: ODT unstable after breaking
Pearls: may cause skin to turn bluish-grey aka "Smurf syndrome"
Maintenence dose: 400-600mg daily in single or divided into bid doses
Warnings: suicidality; not approved for children under 12 years old
Pearls: can cause anticholinergic effects
Pearls: elderly, small or frail patients or adding additional antiHTN therapy, decrease dose by 2.5mg daily
Adverse side effect: cough, HA, dizziness, edema, angioedema, nausea, flushing, fatigue